Literature DB >> 31021251

Seroprevalence of HBV, HCV, and HIV and Associated Risk Factors Among Apparently Healthy Pregnant Women in Anyigba, Nigeria.

Cornelius Arome Omatola1, Christiana Lawal1, Deborah Omolara Omosayin1, Martin-Luther Oseni Okolo1, David Moses Adaji1, Charles Kehinde Mofolorunsho1, Kizito Emeje Bello1.   

Abstract

Globally, infection of pregnant women by human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) pose a significant health challenge for not just the mothers but also the newborn infant. This study was undertaken to assess the prevalence of HIV, HCV, and HBV among pregnant women attending antenatal clinic in Kogi State University Teaching Hospital (KSUTH), Anyigba, Nigeria. Sera samples obtained from 200 consented pregnant women were screened for hepatitis B surface antigen (HBsAg), anti-HCV, and anti-HIV antibodies using commercially available immunoassay test kit. Demographic variables and obstetric characteristic were obtained using structured questionnaire. Of the 200 sera tested, the seroprevalence rates were 1.0%, 0.5%, and 8.5% for HBsAg, anti-HCV, and anti-HIV antibodies, respectively. Although 0.5% were coinfected with HIV/HCV, none was simultaneously infected by the three viruses. Age, marital status, trimester, and educational and occupational status did not significantly affect the prevalence of HIV, HCV, and HBV infections. However, factors such as history of abortion/miscarriage (p = 0.04), intravenous drug use (p = 0.001), and history of other sexually transmitted infection (p = 0.01) were significantly higher in relation to HIV seropositivity. In conclusion, findings from this study revealed high HIV seroprevalence and a clear decline of hepatitis C and B infection prevalence compared with previous epidemiological data. Reason for the latter could be attributed to the current efforts to reduce mother-to-child transmission and possible HBV vaccination programs. High burden of HIV infection in our study suggests the needs to strengthen the national prevention programs including education of the people on the risk factors of HIV transmission.

Entities:  

Keywords:  HBV; HCV; HIV; pregnant women; seroprevalence

Year:  2019        PMID: 31021251     DOI: 10.1089/vim.2018.0140

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  5 in total

1.  Hepatitis B Virus Infection and Its Determinants among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Addisu Alehegn Alemu; Liknaw Bewket Zeleke; Bewket Yesarah Aynalem; Getachew Mullu Kassa
Journal:  Infect Dis Obstet Gynecol       Date:  2020-06-11

2.  Co-infection and Risk Factors Associated with STIs among Pregnant Women in Rural Health Facilities in Nigeria: A Retrospective Study.

Authors:  MaryJoy Umoke; Peter Sage; Tor Bjoernsen; Prince Christian Ifeanachor Umoke; Christian Ezeugworie; Daniel Ejiofor; Ogbonna Agha; Chioma Adaora Nwalieji; Rosemary N Onwe; Ifeanyi Emmanuel Nwafor; Obinna Jude Chukwu
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

3.  A systematic review and meta-analysis of the prevalence of hepatitis B virus infection among pregnant women in Nigeria.

Authors:  Babayemi O Olakunde; Daniel A Adeyinka; Olubunmi A Olakunde; Olalekan A Uthman; Florence O Bada; Yvonne A Nartey; Dorcas Obiri-Yeboah; Elijah Paintsil; Echezona E Ezeanolue
Journal:  PLoS One       Date:  2021-10-29       Impact factor: 3.240

4.  High Seroprevalence of Hepatitis B and C Virus Infections among Pregnant Women Attending Antenatal Clinic in Borumeda General Hospital, Northeast Ethiopia.

Authors:  Daniel Gebretsadik; Minilik Assefa; Genet Molla Fenta; Chala Daba; Abdurrahman Ali; Saba Gebremichael Tekele
Journal:  Biomed Res Int       Date:  2022-08-28       Impact factor: 3.246

5.  Hepatitis B infection and risk factors among pregnant women and their male partners in the Baby Shower Programme in Nigeria: a cross-sectional study.

Authors:  Carol Talla; Ijeoma Uchenna Itanyi; Kiyomi Tsuyuki; Nicole Stadnick; Amaka Grace Ogidi; Babayemi Oluwaseun Olakunde; Dina Patel; John Okpanachi Oko; Gregory Aarons; Chima Ariel Onoka; Echezona Edozie Ezeanolue
Journal:  Trop Med Int Health       Date:  2020-12-10       Impact factor: 2.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.